Atlas Trials

A Study To Assess the Safety of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence

Clinical trial NCT05134649 · COMPLETED

Trial details

NCT number
NCT05134649
Sponsor
AbbVie
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Platysma Prominence
Start date
2021-11-16
Primary completion
2023-08-18
Enrollment
292

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.